J. Cleator

发表

Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record

D. Roden, J. Schildcrout, M. Ritchie, 2012, Clinical pharmacology and therapeutics.

Genome‐wide and candidate gene approaches of clopidogrel efficacy using pharmacodynamic and clinical end points—Rationale and design of the International Clopidogrel Pharmacogenomics Consortium (ICPC)

Joshua P. Lewis, R. Altman, L. Gong, 2017, American heart journal.

Thrombin Modulates the Expression of a Set of Genes Including Thrombospondin-1 in Human Microvascular Endothelial Cells*

H. Hamm, J. Muldowney, D. Vaughan, 2005, Journal of Biological Chemistry.

PAR4, but Not PAR1, Signals Human Platelet Aggregation via Ca2+ Mobilization and Synergistic P2Y12 Receptor Activation*

H. Hamm, M. Holinstat, J. Cleator, 2006, Journal of Biological Chemistry.

A dominant negative Galphas mutant that prevents thyroid-stimulating hormone receptor activation of cAMP production and inositol 1,4,5-trisphosphate turnover: competition by different G proteins for activation by a common receptor.

Roneka L Ravenell, J. Cleator, J. Hildebrandt, 2004, The Journal of biological chemistry.

Pharmacogenomic Polygenic Response Score Predicts Ischemic Events and Cardiovascular Mortality in Clopidogrel-Treated Patients.

R. Altman, L. Gong, T. Klein, 2019, European heart journal. Cardiovascular pharmacotherapy.

Vascular Repair at the Interface of the Endothelium: The Roles of Protease-Activated Receptors and Neuregulin-1

C. Galindo, J. Cleator, O. Odiete, 2014 .

Dichotomous effects of exposure to bivalirudin in patients undergoing percutaneous coronary intervention on protease-activated receptor-mediated platelet activation

H. Hamm, Qingxia Chen, M. Holinstat, 2013, Journal of Thrombosis and Thrombolysis.

Clinical implications of the contrasting effects of in vivo thrombin receptor activation (protease-activated receptor type 1) on the human vasculature.

D. Vaughan, J. Cleator, 2008, Journal of the American College of Cardiology.

Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.

H. Hamm, D. Vaughan, J. Cleator, 2006, Blood.

Evaluation of the F2R IVS-14A/T PAR1 polymorphism with subsequent cardiovascular events and bleeding in patients who have undergone percutaneous coronary intervention

F. Harrell, H. Hamm, D. Roden, 2016, Journal of Thrombosis and Thrombolysis.

Neuregulin (NRG-1β) Is Pro-Myogenic and Anti-Cachectic in Respiratory Muscles of Post-Myocardial Infarcted Swine

D. Sawyer, C. Galindo, J. Cleator, 2022, Biology.

Racial Differences in Resistance to P2Y12 Receptor Antagonists in Type 2 Diabetic Subjects

F. Harrell, H. Hamm, M. Holinstat, 2014, The Journal of Pharmacology and Experimental Therapeutics.

Anti‐Remodeling and Anti‐Fibrotic Effects of the Neuregulin‐1β Glial Growth Factor 2 in a Large Animal Model of Heart Failure

F. Harrell, P. Williams, D. Sawyer, 2014, Journal of the American Heart Association.

Genomewide Association Study of Platelet Reactivity and Cardiovascular Response in Patients Treated With Clopidogrel: A Study by the International Clopidogrel Pharmacogenomics Consortium

R. Altman, L. Gong, T. Klein, 2020, Clinical pharmacology and therapeutics.

Abstract 15531: Neuregulin-1{beta} Improves Cardiac Remodeling After MI in Swine

D. Sawyer, Phillip E. Williams, J. Cleator, 2011 .

The N54 mutant of Gαs has a conditional dominant negative phenotype which suppresses hormone‐stimulated but not basal cAMP levels

J. Cleator, J. Hildebrandt, D. T. Kurtz, 1999, FEBS letters.

Identification of a region in G protein γ subunits conserved across species but hypervariable among subunit isoforms

K. Schey, J. Cleator, J. Hildebrandt, 2001, Protein science : a publication of the Protein Society.

The Link Between Inflammation and Thrombosis

J. Cleator, M. Robbins, 2010 .

Routine intraoperative completion angiography after coronary artery bypass grafting and 1-stop hybrid revascularization results from a fully integrated hybrid catheterization laboratory/operating room.

John A McPherson, S. Hoff, David X M Zhao, 2009, Journal of the American College of Cardiology.

The N54-αs Mutant Has Decreased Affinity for βγ and Suggests a Mechanism for Coupling Heterotrimeric G Protein Nucleotide Exchange with Subunit Dissociation

J. Cleator, J. Hildebrandt, D. T. Kurtz, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Learning curve in transradial cardiac catheterization: procedure-related parameters stratified by operators' transradial volume.

David X M Zhao, J. Cleator, Robert L. Huang, 2012, The Journal of invasive cardiology.

G Protein βγ Dimer Formation: Gβ and Gγ Differentially Determine Efficiency of in Vitro Dimer Formation†

J. Cleator, J. Hildebrandt, K. Robinson, 2005 .

Species‐specific effects of neuregulin‐1&bgr; (cimaglermin alfa) on glucose handling in animal models and humans with heart failure

D. Sawyer, J. Cleator, Zhihong Huang, 2017, Toxicology and applied pharmacology.

A Dominant Negative Gαs Mutant That Prevents Thyroid-stimulating Hormone Receptor Activation of cAMP Production and Inositol 1,4,5-Trisphosphate Turnover

J. Cleator, J. Hildebrandt, D. T. Kurtz, 2004, Journal of Biological Chemistry.

A comparative study of different methods for automatic identification of clopidogrel-induced bleedings in electronic health records

Hua Xu, Yonghui Wu, Joshua C. Denny, 2017, CRI.

How Can we Improve Non-Surgical Septal Reduction for Hypertrophic Obstructive Cardiomyopathy?

D. Sawyer, David X M Zhao, J. Cleator, 2016 .

A comparative study of different methods for automatic identification of clopidogrel-induced bleedings in electronic health records

Yonghui Wu, D. Roden, J. Denny, 2017, CRI.

Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record

Melissa A. Basford, Raquel M. Zink, D. Roden, 2012, Clinical pharmacology and therapeutics.

Differential regulation of endothelial exocytosis of P-selectin and von Willebrand factor by protease-activated receptors and cAMP.

H. Hamm, D. Vaughan, J. Cleator, 2006, Blood.

Physician response to implementation of genotype‐tailored antiplatelet therapy

J M Pulley, D M Roden, J. Schildcrout, 2016, Clinical pharmacology and therapeutics.